US Stock MarketDetailed Quotes

NBY NovaBay Pharmaceuticals

Watchlist
  • 2.0800
  • +0.0800+4.00%
Trading Jul 22 11:05 ET
2.80MMarket Cap-18P/E (TTM)

NovaBay Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NovaBay Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

2.63M

+12.48%
EPS(YoY)

-5.25

+82.35%
Analyst Rating

No Data

NovaBay Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.560M--
--2024/Q2-- / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
Mar 26, 20242023/Q43.727M / 3.400M--
Nov 9, 20232023/Q33.265M / 3.545M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.560M--
--2024/Q2-- / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
Mar 26, 20242023/Q43.727M / 3.400M--
Nov 9, 20232023/Q33.265M / 3.545M--

Unlock Free Earnings Estimates

NovaBay Pharmaceuticals Earnings Reports

  • NovaBay Pharmaceuticals | 10-Q: Quarterly report

    May 9 16:22 ET

  • NovaBay Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 29 11:02 ET

  • NovaBay Pharmaceuticals | 10-K: Annual report

    Mar 26 16:23 ET

  • NovaBay Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg